{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T20:15:34Z","timestamp":1793218534223,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.iac.2022.10.001","type":"journal-article","created":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T18:15:26Z","timestamp":1688148926000},"page":"593-612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Spondyloarthritides"],"prefix":"10.1016","volume":"43","author":[{"given":"Hope A.","family":"Taitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rithvik","family":"Balakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.iac.2022.10.001_bib1","first-page":"2853","article-title":"Spondyloarthropathies","volume":"69","author":"Kataria","year":"2004","journal-title":"Am Fam Physician"},{"issue":"1","key":"10.1016\/j.iac.2022.10.001_bib2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.berh.2012.01.002","article-title":"Spondyloarthropathies","volume":"26","author":"Ehrenfeld","year":"2012","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.iac.2022.10.001_bib3","series-title":"Kelley and Firestein\u2019s textbook of rheumatology","first-page":"1256","article-title":"Ankylosing spondylitis","author":"van der Linden","year":"2017"},{"issue":"10089","key":"10.1016\/j.iac.2022.10.001_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(16)31591-4","article-title":"Axial spondyloarthritis","volume":"390","author":"Sieper","year":"2017","journal-title":"Lancet"},{"issue":"Supplement_4","key":"10.1016\/j.iac.2022.10.001_bib5","doi-asserted-by":"crossref","first-page":"iv6","DOI":"10.1093\/rheumatology\/keaa250","article-title":"Classification vs diagnostic criteria: the challenge of diagnosing axial spondyloarthritis","volume":"59","author":"Poddubnyy","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 2","key":"10.1016\/j.iac.2022.10.001_bib6","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/ard.2008.104018","article-title":"The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis","volume":"68","author":"Sieper","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.iac.2022.10.001_bib7","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection [published correction appears in Ann Rheum Dis. 2019 Jun;78(6):e59]","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.iac.2022.10.001_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.2010.133645","article-title":"The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general","volume":"70","author":"Rudwaleit","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"4\u20135","key":"10.1016\/j.iac.2022.10.001_bib9","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.autrev.2014.01.005","article-title":"Diagnosis and classification of reactive arthritis","volume":"13","author":"Selmi","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.iac.2022.10.001_bib10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s40588-020-00152-6","article-title":"Reactive arthritis: update","volume":"7","author":"Bentaleb","year":"2020","journal-title":"Curr Clin Microbiol Rep"},{"issue":"1","key":"10.1016\/j.iac.2022.10.001_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0049-0172(73)90035-8","article-title":"Psoriatic arthritis","volume":"3","author":"Moll","year":"1973","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.iac.2022.10.001_bib12","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.iac.2022.10.001_bib13","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.berh.2010.05.007","article-title":"Classification criteria for psoriatic arthritis and ankylosing spondylitis\/axial spondyloarthritis","volume":"24","author":"Rudwaleit","year":"2010","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"8","key":"10.1016\/j.iac.2022.10.001_bib14","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1007\/s10067-016-3295-9","article-title":"Psoriatic arthritis and psoriasis: differential diagnosis","volume":"35","author":"Napolitano","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.iac.2022.10.001_bib15","series-title":"Kelley and Firestein\u2019s textbook of rheumatology","first-page":"1285","article-title":"Psoriatic arthritis","author":"FitzGerald","year":"2017"},{"key":"10.1016\/j.iac.2022.10.001_bib16","series-title":"Kelley and Firestein\u2019s textbook of rheumatology","first-page":"1309","article-title":"Enteropathic arthritis","author":"Wollheim","year":"2017"},{"issue":"3","key":"10.1016\/j.iac.2022.10.001_bib17","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0889-857X(03)00043-7","article-title":"Enteropathic arthritis","volume":"29","author":"Holden","year":"2003","journal-title":"Rheum Dis Clin North Am"},{"issue":"1","key":"10.1016\/j.iac.2022.10.001_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/art.23177","article-title":"Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I","volume":"58","author":"Helmick","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.iac.2022.10.001_bib19","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/rheumatology\/ket387","article-title":"Global prevalence of ankylosing spondylitis","volume":"53","author":"Dean","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.iac.2022.10.001_bib20","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/MAJ.0b013e318294457f","article-title":"The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States","volume":"345","author":"Reveille","year":"2013","journal-title":"Am J Med Sci"},{"issue":"2","key":"10.1016\/j.iac.2022.10.001_bib21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3899\/jrheum.181331","article-title":"Peripheral manifestations in spondyloarthritis and their effect: an ancillary analysis of the ASAS-COMOSPA study","volume":"47","author":"L\u00f3pez-Medina","year":"2020","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.iac.2022.10.001_bib22","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.rdc.2012.09.003","article-title":"Epidemiology of spondyloarthritis","volume":"38","author":"Stolwijk","year":"2012","journal-title":"Rheum Dis Clin North Am"},{"issue":"2","key":"10.1016\/j.iac.2022.10.001_bib23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3899\/jrheum.080691","article-title":"Time trends in epidemiology and characteristics of psoriatic arthritis over 3 decades: a population-based study","volume":"36","author":"Wilson","year":"2009","journal-title":"J\u00a0Rheumatol"},{"issue":"12","key":"10.1016\/j.iac.2022.10.001_bib24","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1136\/ard.2007.083451","article-title":"Reactive arthritis following culture-confirmed infections with bacterial enteric pathogens in Minnesota and Oregon: a population-based study","volume":"67","author":"Townes","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.iac.2022.10.001_bib25","first-page":"631","article-title":"The prevalence and incidence of axial and peripheral spondyloarthritis in inflammatory bowel disease: a systematic review and meta-analysis","volume":"11","author":"Karreman","year":"2017","journal-title":"J\u00a0Crohns Colitis"},{"issue":"7","key":"10.1016\/j.iac.2022.10.001_bib26","doi-asserted-by":"crossref","first-page":"514","DOI":"10.7326\/M16-2367","article-title":"Clinical Guidelines Committee of the American College of Physicians. Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American College of Physicians","volume":"166","author":"Qaseem","year":"2017","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.iac.2022.10.001_bib27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/01.JAA.0000684112.91641.4c","article-title":"Red flags of low back pain","volume":"33","author":"DePalma","year":"2020","journal-title":"JAAPA"},{"issue":"7","key":"10.1016\/j.iac.2022.10.001_bib28","first-page":"421","article-title":"Mechanical low back pain","volume":"98","author":"Will","year":"2018","journal-title":"Am Fam Physician"},{"issue":"2","key":"10.1016\/j.iac.2022.10.001_bib29","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.rdc.2020.01.005","article-title":"The future of imaging in axial spondyloarthritis","volume":"46","author":"de Hooge","year":"2020","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.iac.2022.10.001_bib30","series-title":"Musculoskeletal imaging","first-page":"691","article-title":"Ankylosing spondylitis","author":"Schorn","year":"2016"},{"issue":"4","key":"10.1016\/j.iac.2022.10.001_bib31","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.rdc.2015.07.007","article-title":"Imaging in psoriatic arthritis","volume":"41","author":"Poggenborg","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.iac.2022.10.001_bib32","series-title":"Musculoskeletal Imaging","first-page":"684","article-title":"Reactive Arthritis","author":"Nissman","year":"2015"},{"issue":"2","key":"10.1016\/j.iac.2022.10.001_bib33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.rdc.2020.01.008","article-title":"Classification criteria in axial spondyloarthritis: what have we learned; where are we going?","volume":"46","author":"Hayward","year":"2020","journal-title":"Rheum Dis Clin North Am"},{"issue":"2","key":"10.1016\/j.iac.2022.10.001_bib34","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.rdc.2020.01.004","article-title":"Approach to the patient with axial spondyloarthritis and suspected inflammatory bowel disease","volume":"46","author":"Ib\u00e1\u00f1ez Vodnizza","year":"2020","journal-title":"Rheum Dis Clin North Am"},{"issue":"4","key":"10.1016\/j.iac.2022.10.001_bib35","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/art.23275","article-title":"Benefits and risks of ankylosing spondylitis treatment with nonsteroidal antiinflammatory drugs","volume":"58","author":"Song","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.iac.2022.10.001_bib36","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis)","author":"Kroon","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.iac.2022.10.001_bib37","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/acr.24025","article-title":"2019\u00a0Update of the American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis","volume":"71","author":"Ward","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"10.1016\/j.iac.2022.10.001_bib38","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/art.39298","article-title":"American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis","volume":"68","author":"Ward","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.iac.2022.10.001_bib39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/art.40726","article-title":"Special article: 2018 American College of Rheumatology\/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis","volume":"71","author":"Singh","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.iac.2022.10.001_bib40","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/annrheumdis-2020-217159","article-title":"EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update","volume":"79","author":"Gossec","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.iac.2022.10.001_bib41","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.39573","article-title":"Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 treatment recommendations for psoriatic arthritis","volume":"68","author":"Coates","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.iac.2022.10.001_bib42","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X20962623","article-title":"Choosing the right treatment for patients with psoriatic arthritis","volume":"12","author":"Noviani","year":"2020","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"4","key":"10.1016\/j.iac.2022.10.001_bib43","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s40265-014-0191-y","article-title":"Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis","volume":"74","author":"Mease","year":"2014","journal-title":"Drugs"},{"issue":"Supplement_1","key":"10.1016\/j.iac.2022.10.001_bib44","doi-asserted-by":"crossref","first-page":"i37","DOI":"10.1093\/rheumatology\/kez383","article-title":"Treatment guidelines in psoriatic arthritis","volume":"59","author":"Ogdie","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.iac.2022.10.001_bib45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/00063030-200013010-00003","article-title":"Treatment of reactive arthritis: a practical guide","volume":"13","author":"Rudwaleit","year":"2000","journal-title":"BioDrugs"},{"issue":"Suppl 3","key":"10.1016\/j.iac.2022.10.001_bib46","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1093\/cid\/cir702","article-title":"Mycoplasma genitalium: should we treat and how?","volume":"53","author":"Manhart","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.iac.2022.10.001_bib47","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.autrev.2014.04.003","article-title":"Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease","volume":"13","author":"Olivieri","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.iac.2022.10.001_bib48","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ejmech.2018.09.027","article-title":"Side effects of methotrexate therapy for rheumatoid arthritis: a systematic review","volume":"158","author":"Wang","year":"2018","journal-title":"Eur J Med Chem"},{"issue":"4","key":"10.1016\/j.iac.2022.10.001_bib49","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1756-185X.2010.01564.x","article-title":"Low-dose and high-dose methotrexate are two different drugs in practical terms","volume":"13","author":"Malaviya","year":"2010","journal-title":"Int J Rheum Dis"},{"issue":"Suppl 1","key":"10.1016\/j.iac.2022.10.001_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-198600321-00003","article-title":"Sulphasalazine: a review of 40 years' experience","volume":"32","author":"Watkinson","year":"1986","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.iac.2022.10.001_bib51","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/rheumatology\/36.3.382","article-title":"Sulphasalazine in the treatment of rheumatoid arthritis","volume":"36","author":"Box","year":"1997","journal-title":"Br J Rheumatol"},{"issue":"2","key":"10.1016\/j.iac.2022.10.001_bib52","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.idc.2010.01.006","article-title":"Infectious complications associated with immunomodulating biologic agents","volume":"24","author":"Koo","year":"2010","journal-title":"Infect Dis Clin North Am"},{"issue":"6","key":"10.1016\/j.iac.2022.10.001_bib53","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1572-0241.2003.07457.x","article-title":"The incidence and management of infusion reactions to infliximab: a large center experience","volume":"98","author":"Cheifetz","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.iac.2022.10.001_bib54","first-page":"99","article-title":"Central nervous system demyelination associated with etanercept in a 51 years old woman","volume":"2","author":"Ibrahim","year":"2007","journal-title":"Libyan J Med"},{"issue":"9","key":"10.1016\/j.iac.2022.10.001_bib55","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/annrheumdis-2020-217927","article-title":"Paradoxical gastrointestinal effects of interleukin-17 blockers","volume":"79","author":"Fauny","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.iac.2022.10.001_bib56","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/1744666X.2020.1803063","article-title":"Ixekizumab for the treatment of ankylosing spondylitis","volume":"16","author":"Huang","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"issue":"9625","key":"10.1016\/j.iac.2022.10.001_bib57","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(08)60725-4","article-title":"Efficacy and safety of ustekinumab, a human interleukin-12\/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)","volume":"371","author":"Leonardi","year":"2008","journal-title":"Lancet"},{"issue":"9625","key":"10.1016\/j.iac.2022.10.001_bib58","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/S0140-6736(08)60726-6","article-title":"Efficacy and safety of ustekinumab, a human interleukin-12\/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)","volume":"371","author":"Papp","year":"2008","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.iac.2022.10.001_bib59","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1136\/ard.2008.092163","article-title":"Dose-related patterns of glucocorticoid-induced side effects","volume":"68","author":"Huscher","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.iac.2022.10.001_bib60","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.pop.2018.02.005","article-title":"The seronegative spondyloarthropathies","volume":"45","author":"Duba","year":"2018","journal-title":"Prim Care"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856122008980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856122008980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:53:10Z","timestamp":1760179990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856122008980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0889856122008980"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2022.10.001","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spondyloarthritides","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2022.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}